By investigating exosome-associated biomarkers in breast cancer patients undergoing chemotherapy, Wang et al. found that the circulating exosomes carrying TRPC5 were significantly correlated with the expression level of TRPC5 in breast cancer tissues and response to chemotherapy. Here, TRPC5 is linked to breast carcinoma.